Mads Daugaard

6.6k total citations · 2 hit papers
56 papers, 3.5k citations indexed

About

Mads Daugaard is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mads Daugaard has authored 56 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Mads Daugaard's work include DNA Repair Mechanisms (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Cancer-related Molecular Pathways (6 papers). Mads Daugaard is often cited by papers focused on DNA Repair Mechanisms (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Cancer-related Molecular Pathways (6 papers). Mads Daugaard collaborates with scholars based in Canada, Denmark and United States. Mads Daugaard's co-authors include Marja Jäättelä, Mikkel Rohde, Jesper Nylandsted, Kristian Helin, Poul H. Sorensen, Emma S. Tomlinson Guns, Erfan Taatizadeh, Mina Hoorfar, Cathie Garnis and Nishat Tasnim and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mads Daugaard

51 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions

2007 884 citations Mads Daugaard, Mikkel Rohde et al. profile →
Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy

2019 428 citations Mads Daugaard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mads Daugaard Canada	23	2.4k	704	510	510	462	56	3.5k
Miguel Mano Italy	30	3.0k 1.3×	539 0.8×	755 1.5×	1.1k 2.1×	335 0.7×	54	4.3k
Raghothama Chaerkady United States	37	2.4k 1.0×	399 0.6×	270 0.5×	474 0.9×	393 0.9×	91	3.6k
Makoto Adachi Japan	28	3.1k 1.3×	606 0.9×	868 1.7×	328 0.6×	352 0.8×	103	4.6k
Glen M. Boyle Australia	42	2.6k 1.1×	1.2k 1.7×	414 0.8×	787 1.5×	898 1.9×	129	5.0k
Vasu Punj United States	35	1.9k 0.8×	786 1.1×	181 0.4×	659 1.3×	393 0.9×	79	3.4k
Igor Paron Italy	18	4.1k 1.7×	493 0.7×	642 1.3×	346 0.7×	596 1.3×	21	5.9k
Oded Kleifeld Israel	31	2.6k 1.1×	1.3k 1.8×	452 0.9×	1.0k 2.0×	368 0.8×	79	4.3k
Timothy Spicer United States	32	1.5k 0.6×	415 0.6×	372 0.7×	206 0.4×	394 0.9×	130	3.3k
Duncan L. Smith United Kingdom	28	1.8k 0.8×	490 0.7×	350 0.7×	528 1.0×	213 0.5×	50	2.8k
Mariola J. Edelmann United States	35	3.2k 1.3×	574 0.8×	364 0.7×	857 1.7×	570 1.2×	70	4.3k

Countries citing papers authored by Mads Daugaard

Since Specialization

Citations

This map shows the geographic impact of Mads Daugaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mads Daugaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mads Daugaard more than expected).

Fields of papers citing papers by Mads Daugaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mads Daugaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mads Daugaard. The network helps show where Mads Daugaard may publish in the future.

Co-authorship network of co-authors of Mads Daugaard

This figure shows the co-authorship network connecting the top 25 collaborators of Mads Daugaard. A scholar is included among the top collaborators of Mads Daugaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mads Daugaard. Mads Daugaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Ning, Hui Xue, Nelson K.Y. Wong, et al.. (2025). Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities. Molecular Cancer Research. 23(4). 327–338.

Roberts, Morgan E., et al.. (2024). Pulsed Photothermal Therapy of Solid Tumors as a Precondition for Immunotherapy. Small. 20(32). e2309495–e2309495. 11 indexed citations

Unal, Bilal, Omer F. Kuzu, Yang Jin, et al.. (2024). Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer. Nature Communications. 15(1). 8895–8895. 20 indexed citations

Unal, Bilal, Omer F. Kuzu, Yang Jin, et al.. (2024). Abstract 5362: Targeting IRE1α alleviates the immunosuppressive tumor microenvironment in prostate cancer. Cancer Research. 84(6_Supplement). 5362–5362.

Zhai, Beibei, Fariba Ghaidi, Michael M. Lizardo, et al.. (2023). A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma. Clinical Cancer Research. 29(17). 3541–3553. 19 indexed citations

Roberts, Morgan E., Elie Ritch, Joshua Scurll, et al.. (2023). A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer. iScience. 26(5). 106525–106525. 5 indexed citations

Petracchini, Serena, Anne Doye, Atef Asnacios, et al.. (2022). Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division. Nature Communications. 13(1). 6059–6059. 14 indexed citations

Richards, Rebecca M., Feifei Zhao, Katherine A. Freitas, et al.. (2021). NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity. Blood Cancer Discovery. 2(6). 648–665. 65 indexed citations

Hou, Huayun, Marat Mufteev, Bin Yu, et al.. (2021). Alternative polyadenylation is a determinant of oncogenic Ras function. Science Advances. 7(51). eabh0562–eabh0562. 6 indexed citations

10.

Kranenburg, Onno, et al.. (2021). A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity. Cells. 10(5). 1262–1262. 12 indexed citations

11.

Oo, Htoo Zarni, Gholamreza Safaee Ardekani, Nader Al Nakouzi, et al.. (2020). VAR2-armed CAR T-cells as an immunotherapeutic strategy for bladder cancer. European Urology Open Science. 19. e105–e105.

12.

Clausen, Thomas Mandel, Antonio Hurtado‐Coll, Tobias Gustavsson, et al.. (2020). A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine. Cell Death Discovery. 6(1). 65–65. 7 indexed citations

13.

Grigor, Emma, Dean Fergusson, Natasha Kekre, et al.. (2019). Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis. Transfusion Medicine Reviews. 33(2). 98–110. 132 indexed citations

14.

Oo, Htoo Zarni, Roland Seiler, Peter C. Black, & Mads Daugaard. (2018). Post-translational modifications in bladder cancer: Expanding the tumor target repertoire. Urologic Oncology Seminars and Original Investigations. 38(12). 858–866. 17 indexed citations

15.

Grigor, Emma, Dean Fergusson, Fatima Haggar, et al.. (2017). Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis. BMJ Open. 7(12). e019321–e019321. 20 indexed citations

16.

Clausen, Thomas Mandel, Marina Ayres Pereira, Nader Al Nakouzi, et al.. (2016). Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. Molecular Cancer Research. 14(12). 1288–1299. 46 indexed citations

17.

Pereira, Marina Ayres, Thomas Mandel Clausen, Caroline Pehrson, et al.. (2016). Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathogens. 12(8). e1005831–e1005831. 70 indexed citations

18.

Baude, Annika, Tania Løve Aaes, Beibei Zhai, et al.. (2015). Hepatoma-derived growth factor-related protein 2 promotes DNA repair by homologous recombination. Nucleic Acids Research. 44(5). 2214–2226. 34 indexed citations

19.

Farkas, Thomas, Mads Daugaard, & Marja Jäättelä. (2011). Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy. Journal of Biological Chemistry. 286(45). 38904–38912. 72 indexed citations

20.

Daugaard, Mads, Marja Jäättelä, & Mikkel Rohde. (2005). Hsp70-2 is Required for Tumor Cell Growth and Survival. Cell Cycle. 4(7). 877–880. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact